Merck Serono Ventures, Compugen Team Up On Drug Toxicity Biomarker Start-Up
Partnership is first investment under Merck Serono Ventures’ €10 million Israel Bioincubator Program.
Partnership is first investment under Merck Serono Ventures’ €10 million Israel Bioincubator Program.